Visit our COVID-19 Experts Directory to find UC San Diego sources who are available to discuss with the media the novel coronavirus, the COVID-19 illness and the societal impacts of the pandemic.
A recent study by researchers at University of California San Diego School of Medicine suggests transmission of COVID-19 through breast milk is not likely. The infectious virus was not detected in 64 samples of breast milk tested.
The University of California San Diego has been named the fourth best public university in the United States for the second consecutive year by the 2020 Academic Ranking of World Universities (ARWU).
As part of the he university’s Return to Learn program, Dr. Robert Schooley, a professor in the Department of Medicine at UC San Diego School of Medicine, addresses questions about how the university is involved in vaccine development, how the SARS-CoV-2 virus spreads and the importance of wearing…
The COVID-19 pandemic ushered in a new era of online learning that has allowed colleges and universities to explore the full potential that remote delivery of services and instruction can offer. Enrollment in UC San Diego’s remote-instruction summer session has skyrocketed.
UC San Diego’s fall plan is continually evolving, informed by the university’s Return to Learn program. We invited students, faculty and staff to submit their questions, including inquiries about what services are available during isolation housing, what move-in will look like this fall, as well…
UC San Diego Health nurse helps start farm that will provide free food to community in Mexico hurt by COVID-19.
UC San Diego’s fall plan is continually evolving, informed by the university’s Return to Learn program. We invited students, faculty and staff to submit their questions about the overarching goal of the program, how contact tracing happens, what instructions are provided to those who may have been…
UC San Diego Health and the Altman Clinical and Translational Research Institute will be sites for an accelerated national clinical trial to assess the efficacy and immunogenicity of a vaccine intended to protect against SARS-CoV-2, the coronavirus that causes COVID-19.
In the midst of the unprecedented COVID-19 pandemic that had UC San Diego researchers racing to understand the complexities around the virus’s spread and to find ways to combat it, engineers and fabrication specialists at the Qualcomm Institute’s Prototyping Lab leapt into action.